SACUBITRIL AND VALSARTAN

SACUBITRIL AND VALSARTAN was reported 116184 times

SACUBITRIL AND VALSARTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE INAPPROPRIATE SHOCK DELIVERY 36 0.4615
1 THROAT CLEARING 1549 0.4128
2 EJECTION FRACTION ABNORMAL 429 0.3499
3 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 243 0.1730
4 LEFT VENTRICULAR ENLARGEMENT 43 0.1686
5 EJECTION FRACTION DECREASED 2511 0.1614
6 VENTRICULAR ENLARGEMENT 27 0.1534
7 INFERIOR VENA CAVA DILATATION 32 0.1517
8 EJECTION FRACTION 86 0.1480
9 CARDIAC FAILURE CHRONIC 615 0.1442
10 CARDIAC DYSFUNCTION 531 0.1426
11 BRAIN NATRIURETIC PEPTIDE ABNORMAL 27 0.1262
12 CHRONIC LEFT VENTRICULAR FAILURE 45 0.1250
13 LEFT ATRIAL ENLARGEMENT 63 0.1169
14 WEIGHT FLUCTUATION 1141 0.1089
15 BLOOD POTASSIUM INCREASED 1418 0.0872
16 LOW CARDIAC OUTPUT SYNDROME 29 0.0868
17 BLOOD PRESSURE SYSTOLIC DECREASED 380 0.0835
18 CONCOMITANT DISEASE AGGRAVATED 508 0.0822
19 BRAIN NATRIURETIC PEPTIDE INCREASED 250 0.0810
20 LEFT VENTRICULAR DILATATION 41 0.0802
21 PRESCRIBED UNDERDOSE 1592 0.0797
22 CARDIORENAL SYNDROME 43 0.0750
23 DIZZINESS POSTURAL 687 0.0708
24 DYSPNOEA PAROXYSMAL NOCTURNAL 50 0.0686
25 FLUID IMBALANCE 48 0.0682
26 ORTHOPNOEA 214 0.0671
27 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 35 0.0669
28 SYSTOLIC DYSFUNCTION 65 0.0617
29 ISCHAEMIC CARDIOMYOPATHY 188 0.0613
30 CARDIAC OUTPUT DECREASED 54 0.0612
31 GLYCOSYLATED HAEMOGLOBIN DECREASED 95 0.0590
32 HYPOTENSION 11679 0.0582
33 CARDIAC FAILURE 4550 0.0566
34 JUGULAR VEIN DISTENSION 32 0.0564
35 DILATED CARDIOMYOPATHY 57 0.0564
36 HEART FAILURE WITH REDUCED EJECTION FRACTION 30 0.0561
37 HEART VALVE INCOMPETENCE 158 0.0551
38 HYPOACUSIS 2359 0.0547
39 DECREASED ACTIVITY 589 0.0545
40 AORTIC VALVE CALCIFICATION 27 0.0525
41 NASAL PRURITUS 65 0.0519
42 ECHOCARDIOGRAM ABNORMAL 69 0.0493
43 BLOOD PRESSURE DECREASED 3216 0.0484
44 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 30 0.0467
45 CARDIAC ANEURYSM 46 0.0463
46 DIZZINESS EXERTIONAL 35 0.0461
47 FLUID RETENTION 2290 0.0450
48 OXYGEN CONSUMPTION DECREASED 27 0.0446
49 BLOOD POTASSIUM ABNORMAL 118 0.0442
50 ALLERGIC COUGH 33 0.0429
51 CONGESTIVE CARDIOMYOPATHY 174 0.0417
52 GLOMERULAR FILTRATION RATE DECREASED 506 0.0411
53 NEAR DEATH EXPERIENCE 135 0.0409
54 BLOOD CHOLESTEROL DECREASED 75 0.0402
55 CARDIAC FAILURE ACUTE 261 0.0391
56 CARDIAC AMYLOIDOSIS 43 0.0391
57 PRODUCT PRESCRIBING ERROR 898 0.0377
58 WEIGHT ABNORMAL 90 0.0375
59 INFARCTION 254 0.0371
60 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7341 0.0362
61 HEART RATE ABNORMAL 199 0.0357
62 VENTRICULAR HYPOKINESIA 114 0.0355
63 BUNDLE BRANCH BLOCK LEFT 149 0.0351
64 LEFT VENTRICULAR DYSFUNCTION 235 0.0350
65 LAZINESS 59 0.0345
66 MITRAL VALVE INCOMPETENCE 378 0.0334
67 BLOOD CREATINE INCREASED 146 0.0329
68 LEFT VENTRICULAR FAILURE 112 0.0325
69 CARDIOMYOPATHY 470 0.0318
70 SUBCLAVIAN VEIN THROMBOSIS 36 0.0316
71 EXERCISE TOLERANCE DECREASED 182 0.0316
72 BLOOD PRESSURE ABNORMAL 624 0.0314
73 HEART RATE DECREASED 1094 0.0311
74 BLOOD SODIUM INCREASED 84 0.0311
75 HYPERKALAEMIA 1087 0.0310
76 CARDIAC VENTRICULAR THROMBOSIS 39 0.0302
77 VENTRICULAR TACHYCARDIA 497 0.0301
78 DIASTOLIC DYSFUNCTION 92 0.0298
79 LEFT ATRIAL DILATATION 37 0.0290
80 VENTRICULAR DYSFUNCTION 75 0.0289
81 CONTRAINDICATED PRODUCT ADMINISTERED 859 0.0283
82 COUGH 7892 0.0281
83 CARDIAC DISORDER 2594 0.0277
84 ENERGY INCREASED 163 0.0276
85 CARDIOMEGALY 336 0.0273
86 CARDIOVASCULAR INSUFFICIENCY 44 0.0270
87 ESSENTIAL HYPERTENSION 49 0.0267
88 HYPERVOLAEMIA 132 0.0267
89 BUNDLE BRANCH BLOCK 25 0.0266
90 BRONCHIAL HYPERREACTIVITY 32 0.0266
91 INTRACARDIAC THROMBUS 81 0.0264
92 VENTRICULAR ARRHYTHMIA 96 0.0262
93 VENTRICULAR EXTRASYSTOLES 270 0.0260
94 CARDIAC VALVE DISEASE 145 0.0253
95 ATRIOVENTRICULAR BLOCK 192 0.0248
96 HYPERTENSIVE HEART DISEASE 46 0.0246
97 CONCOMITANT DISEASE PROGRESSION 48 0.0245
98 BLOOD SODIUM ABNORMAL 26 0.0245
99 TRICUSPID VALVE INCOMPETENCE 194 0.0244
100 IMPLANTABLE DEFIBRILLATOR INSERTION 32 0.0242
101 BLOOD PRESSURE FLUCTUATION 574 0.0239
102 LEFT VENTRICULAR HYPERTROPHY 101 0.0236
103 AORTIC VALVE STENOSIS 42 0.0235
104 CARDIAC FLUTTER 152 0.0235
105 PERIPHERAL ARTERY OCCLUSION 33 0.0235
106 RENAL DISORDER 1085 0.0233
107 AORTIC VALVE INCOMPETENCE 99 0.0232
108 GOUT 411 0.0229
109 PRODUCT MONITORING ERROR 33 0.0228
110 CARDIAC DISCOMFORT 46 0.0228
111 PULMONARY FUNCTION TEST ABNORMAL 35 0.0225
112 POOR PERIPHERAL CIRCULATION 95 0.0223
113 PULMONARY OEDEMA 996 0.0222
114 ATRIAL FIBRILLATION 2165 0.0222
115 URINE OUTPUT INCREASED 58 0.0222
116 APPARENT DEATH 80 0.0222
117 BLOOD SODIUM DECREASED 418 0.0222
118 NOCTURNAL DYSPNOEA 28 0.0219
119 DYSPNOEA EXERTIONAL 825 0.0219
120 MARASMUS 33 0.0217
121 GLOMERULAR FILTRATION RATE ABNORMAL 30 0.0212
122 SLUGGISHNESS 216 0.0212
123 POLLAKIURIA 883 0.0212
124 RENAL FUNCTION TEST ABNORMAL 98 0.0211
125 DYSPNOEA AT REST 61 0.0210
126 OVERWEIGHT 113 0.0210
127 AMYLOIDOSIS 36 0.0209
128 SUDDEN CARDIAC DEATH 71 0.0208
129 HEART RATE IRREGULAR 469 0.0207
130 BLOOD CREATININE INCREASED 1326 0.0203
131 NIPPLE PAIN 41 0.0201
132 RENAL IMPAIRMENT 1677 0.0199
133 ORTHOSTATIC HYPOTENSION 345 0.0198
134 NORMOCYTIC ANAEMIA 29 0.0197
135 ATRIAL FLUTTER 157 0.0197
136 CARDIAC FAILURE CONGESTIVE 1566 0.0195
137 BODY MASS INDEX INCREASED 26 0.0192
138 SEASONAL ALLERGY 271 0.0191
139 ARTERIAL OCCLUSIVE DISEASE 149 0.0189
140 WEIGHT DECREASED 5230 0.0187
141 MITRAL VALVE DISEASE 33 0.0186
142 BLOOD CHLORIDE INCREASED 32 0.0185
143 OBSTRUCTIVE SLEEP APNOEA SYNDROME 27 0.0185
144 BLOOD UREA INCREASED 309 0.0184
145 WEIGHT LOSS POOR 94 0.0184
146 PULSE ABNORMAL 44 0.0182
147 CARDIOGENIC SHOCK 257 0.0179
148 ANGINA PECTORIS 510 0.0178
149 ARRHYTHMIA 835 0.0176
150 DIZZINESS 8785 0.0176
151 READING DISORDER 40 0.0175
152 PHYSICAL DECONDITIONING 45 0.0175
153 DEAFNESS 457 0.0175
154 MYOCARDIAL NECROSIS MARKER INCREASED 29 0.0173
155 ACUTE PULMONARY OEDEMA 97 0.0173
156 AORTIC STENOSIS 60 0.0172
157 DRUG PRESCRIBING ERROR 331 0.0172
158 CORONARY ARTERY STENOSIS 86 0.0171
159 MEMORY IMPAIRMENT 2330 0.0169
160 DEMENTIA 471 0.0168
161 POLYURIA 137 0.0167
162 BLOOD URIC ACID INCREASED 96 0.0166
163 GLUCOSE TOLERANCE IMPAIRED 98 0.0166
164 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 67 0.0164
165 SLEEP APNOEA SYNDROME 313 0.0164
166 HYPOKINESIA 237 0.0163
167 ATRIAL TACHYCARDIA 34 0.0162
168 MYOCARDIAL INFARCTION 2793 0.0160
169 DYSPNOEA 9055 0.0160
170 BLOOD CREATININE ABNORMAL 55 0.0159
171 WEIGHT INCREASED 3520 0.0157
172 CORONARY ARTERY OCCLUSION 212 0.0154
173 PERICARDIAL EFFUSION 356 0.0154
174 EXTRASYSTOLES 107 0.0153
175 DIABETES MELLITUS 1167 0.0153
176 ANGIOEDEMA 672 0.0152
177 BLOOD PRESSURE DIASTOLIC DECREASED 112 0.0152
178 INTRA-ABDOMINAL FLUID COLLECTION 27 0.0151
179 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2704 0.0150
180 PERIPHERAL SWELLING 2285 0.0148
181 SINUS NODE DYSFUNCTION 27 0.0147
182 RALES 85 0.0146
183 ASPHYXIA 118 0.0144
184 ILLNESS 1466 0.0142
185 FRUSTRATION TOLERANCE DECREASED 114 0.0141
186 PULMONARY CONGESTION 185 0.0140
187 BLOOD PHOSPHORUS INCREASED 38 0.0139
188 URINE OUTPUT DECREASED 121 0.0138
189 DISCOURAGEMENT 32 0.0137
190 VENTRICULAR FIBRILLATION 152 0.0137
191 ANEURYSM 68 0.0136
192 SUDDEN DEATH 143 0.0135
193 RESPIRATION ABNORMAL 93 0.0135
194 DYSLIPIDAEMIA 68 0.0134
195 BREATH SOUNDS ABNORMAL 66 0.0134
196 BLOOD POTASSIUM DECREASED 400 0.0133
197 ARTERIOSCLEROSIS 125 0.0133
198 EYE CONTUSION 28 0.0132
199 SLEEP DEFICIT 28 0.0132
200 CAROTID ARTERY STENOSIS 46 0.0132
201 RHINORRHOEA 845 0.0131
202 PRODUCT AVAILABILITY ISSUE 295 0.0129
203 RENAL PAIN 136 0.0128
204 SNEEZING 286 0.0127
205 ELECTROCARDIOGRAM T WAVE INVERSION 28 0.0127
206 LIMB DISCOMFORT 391 0.0126
207 BLOOD PRESSURE INADEQUATELY CONTROLLED 76 0.0126
208 OROPHARYNGEAL DISCOMFORT 113 0.0125
209 PRESYNCOPE 304 0.0125
210 HYPOVOLAEMIA 73 0.0125
211 PERIPHERAL VASCULAR DISORDER 64 0.0124
212 DRY THROAT 126 0.0124
213 PARANASAL SINUS HYPERSECRETION 47 0.0123
214 WEIGHT BEARING DIFFICULTY 33 0.0122
215 GLYCOSYLATED HAEMOGLOBIN INCREASED 307 0.0122
216 OEDEMA 658 0.0121
217 HEART RATE INCREASED 1198 0.0121
218 DUODENITIS 37 0.0120
219 COVID-19 2114 0.0120
220 FEAR OF DEATH 27 0.0120
221 BLOOD PRESSURE SYSTOLIC INCREASED 234 0.0120
222 LOCALISED OEDEMA 55 0.0119
223 HYPERTENSION 2512 0.0118
224 EYE INJURY 36 0.0118
225 UNDERDOSE 865 0.0118
226 PROSTATIC DISORDER 65 0.0118
227 ELECTROCARDIOGRAM ABNORMAL 92 0.0117
228 SINUS DISORDER 231 0.0117
229 GAIT INABILITY 389 0.0116
230 PRODUCT DOSE OMISSION IN ERROR 324 0.0114
231 HIGH DENSITY LIPOPROTEIN DECREASED 38 0.0114
232 DYSSTASIA 333 0.0114
233 SYNCOPE 1140 0.0114
234 ACUTE KIDNEY INJURY 1734 0.0113
235 RED CELL DISTRIBUTION WIDTH INCREASED 47 0.0113
236 AORTIC ARTERIOSCLEROSIS 29 0.0113
237 LIMB INJURY 306 0.0113
238 FATIGUE 8758 0.0112
239 DYSGRAPHIA 74 0.0112
240 FEELING ABNORMAL 2681 0.0112
241 CHOKING 218 0.0112
242 CEREBROVASCULAR ACCIDENT 1883 0.0111
243 MUSCULOSKELETAL DISCOMFORT 191 0.0111
244 ANURIA 95 0.0110
245 THERAPEUTIC RESPONSE UNEXPECTED 490 0.0109
246 NECK INJURY 32 0.0109
247 SWELLING 1017 0.0109
248 PERIPHERAL VENOUS DISEASE 44 0.0108
249 CORONAVIRUS INFECTION 71 0.0107
250 BACK DISORDER 173 0.0106
251 DEATH 9164 0.0106
252 INCORRECT DOSAGE ADMINISTERED 52 0.0106
253 PERIPHERAL COLDNESS 146 0.0106
254 BLOOD PRESSURE DIASTOLIC INCREASED 49 0.0106
255 CATHETERISATION CARDIAC 47 0.0106
256 MUSCLE STRAIN 91 0.0105
257 PRODUCTIVE COUGH 502 0.0105
258 CHEST PAIN 1912 0.0103
259 DEHYDRATION 1374 0.0103
260 BACK INJURY 112 0.0103
261 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 535 0.0102
262 ASTHENIA 3844 0.0102
263 MALAISE 4473 0.0102
264 UPPER-AIRWAY COUGH SYNDROME 84 0.0102
265 RENAL FAILURE 1350 0.0102
266 AMNESIA 660 0.0101
267 NOCTURIA 123 0.0101
268 TEMPERATURE INTOLERANCE 104 0.0101
269 SPEECH DISORDER 519 0.0099
270 NASOPHARYNGITIS 1823 0.0099
271 CEREBRAL DISORDER 73 0.0099
272 BLOOD MAGNESIUM DECREASED 85 0.0098
273 PRODUCT DOSE OMISSION ISSUE 2873 0.0098
274 YAWNING 26 0.0097
275 THIRST 174 0.0097
276 HYPOVOLAEMIC SHOCK 46 0.0096
277 BLOOD PRESSURE INCREASED 1468 0.0096
278 INTERNATIONAL NORMALISED RATIO ABNORMAL 33 0.0096
279 CARDIAC ARREST 785 0.0095
280 LOSS OF CONSCIOUSNESS 1218 0.0095
281 OEDEMA PERIPHERAL 1155 0.0095
282 APHONIA 132 0.0094
283 GENERALISED OEDEMA 117 0.0094
284 SPINAL STENOSIS 39 0.0094
285 VISUAL IMPAIRMENT 1165 0.0094
286 CHEST DISCOMFORT 954 0.0093
287 BLOOD CHOLESTEROL ABNORMAL 43 0.0093
288 SCIATICA 147 0.0092
289 ACCIDENT 110 0.0092
290 AORTIC ANEURYSM 70 0.0092
291 VEIN DISORDER 46 0.0092
292 CORONARY ARTERY DISEASE 278 0.0092
293 FACIAL BONES FRACTURE 33 0.0092
294 MYOCARDIAL ISCHAEMIA 104 0.0091
295 SENSITIVITY TO WEATHER CHANGE 48 0.0091
296 SUSPECTED COVID-19 30 0.0091
297 GAIT DISTURBANCE 1740 0.0091
298 ANGINA UNSTABLE 59 0.0091
299 BLINDNESS 367 0.0090
300 HYPERSOMNIA 257 0.0090
301 PLANTAR FASCIITIS 30 0.0089
302 JOINT INJURY 190 0.0089
303 SKIN ABRASION 42 0.0089
304 DIABETIC FOOT 27 0.0088
305 DRUG INTOLERANCE 850 0.0088
306 LIGAMENT SPRAIN 87 0.0088
307 DYSPHONIA 514 0.0088
308 CARDIAC MURMUR 76 0.0088
309 AZOTAEMIA 35 0.0088
310 PLEURAL EFFUSION 533 0.0088
311 CREATININE RENAL CLEARANCE DECREASED 35 0.0087
312 LIP SWELLING 291 0.0087
313 OLIGURIA 54 0.0087
314 PROSTATOMEGALY 34 0.0086
315 BLOOD CREATININE DECREASED 27 0.0086
316 NO ADVERSE EVENT 1554 0.0086
317 MOVEMENT DISORDER 274 0.0085
318 VARICOSE VEIN 44 0.0085
319 BLOOD GLUCOSE DECREASED 406 0.0084
320 ARTERIOSCLEROSIS CORONARY ARTERY 56 0.0084
321 NEPHROGENIC ANAEMIA 39 0.0084
322 FLUID INTAKE REDUCED 42 0.0084
323 FALL 2766 0.0083
324 COVID-19 PNEUMONIA 98 0.0083
325 POOR QUALITY SLEEP 178 0.0083
326 PULMONARY HYPERTENSION 172 0.0082
327 EMBOLISM VENOUS 25 0.0082
328 INTERNAL HAEMORRHAGE 94 0.0082
329 BLOOD GLUCOSE FLUCTUATION 90 0.0082
330 MACULAR DEGENERATION 98 0.0082
331 DEPRESSED MOOD 432 0.0082
332 RIB FRACTURE 168 0.0082
333 CHOKING SENSATION 45 0.0082
334 INTERNATIONAL NORMALISED RATIO DECREASED 33 0.0081
335 BENIGN PROSTATIC HYPERPLASIA 42 0.0081
336 PRODUCT SUPPLY ISSUE 58 0.0081
337 HEAD INJURY 257 0.0081
338 FLUID OVERLOAD 118 0.0081
339 PRODUCT USE IN UNAPPROVED INDICATION 2006 0.0081
340 ATRIOVENTRICULAR BLOCK COMPLETE 54 0.0081
341 ANGIOPATHY 45 0.0080
342 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 571 0.0080
343 BLOOD IRON DECREASED 95 0.0080
344 MOUTH SWELLING 46 0.0080
345 BRADYKINESIA 47 0.0080
346 FACE INJURY 30 0.0079
347 HIP FRACTURE 254 0.0079
348 HAEMOGLOBIN INCREASED 36 0.0079
349 NEOPLASM MALIGNANT 526 0.0079
350 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 26 0.0078
351 THROAT CANCER 33 0.0078
352 HEAD DISCOMFORT 138 0.0078
353 HYPERURICAEMIA 32 0.0078
354 PROSTATE CANCER METASTATIC 26 0.0078
355 PHARYNGEAL SWELLING 76 0.0078
356 TROPONIN INCREASED 59 0.0077
357 THYROID DISORDER 119 0.0077
358 ACUTE MYOCARDIAL INFARCTION 227 0.0077
359 SUPRAVENTRICULAR EXTRASYSTOLES 26 0.0077
360 BLOOD GLUCOSE ABNORMAL 142 0.0077
361 ARTHRITIS 598 0.0076
362 SARS-COV-2 TEST POSITIVE 100 0.0076
363 APHASIA 227 0.0075
364 MICTURITION DISORDER 26 0.0075
365 GASTROENTERITIS VIRAL 134 0.0074
366 CAROTID ARTERY OCCLUSION 27 0.0074
367 HAEMORRHOIDAL HAEMORRHAGE 36 0.0074
368 PALPITATIONS 863 0.0074
369 GASTRITIS EROSIVE 34 0.0073
370 LETHARGY 418 0.0073
371 HYPERTHYROIDISM 105 0.0072
372 BLOOD DISORDER 58 0.0072
373 SCRATCH 76 0.0072
374 LOWER LIMB FRACTURE 138 0.0072
375 FEAR 193 0.0072
376 PEMPHIGOID 54 0.0071
377 NERVE COMPRESSION 66 0.0071
378 CEREBRAL INFARCTION 174 0.0071
379 TASTE DISORDER 144 0.0071
380 FOOD POISONING 38 0.0071
381 LYMPHOEDEMA 49 0.0071
382 URINE ABNORMALITY 32 0.0070
383 THYROID MASS 27 0.0070
384 NASAL CONGESTION 412 0.0070
385 PRODUCT DISPENSING ERROR 152 0.0070
386 BALANCE DISORDER 600 0.0069
387 INITIAL INSOMNIA 71 0.0069
388 PROTEIN TOTAL DECREASED 26 0.0069
389 IRON DEFICIENCY 31 0.0069
390 DIABETIC NEUROPATHY 34 0.0069
391 SWOLLEN TONGUE 214 0.0068
392 GANGRENE 41 0.0068
393 APPETITE DISORDER 45 0.0068
394 LEUKAEMIA 64 0.0068
395 BRAIN INJURY 68 0.0068
396 JOINT SWELLING 814 0.0067
397 INGUINAL HERNIA 41 0.0067
398 BOWEL MOVEMENT IRREGULARITY 51 0.0067
399 HYPERNATRAEMIA 33 0.0066
400 HYPERSENSITIVITY 1220 0.0066
401 SLEEP DISORDER 463 0.0066
402 BRADYCARDIA 347 0.0065
403 SHOCK 150 0.0065
404 HYPERPHAGIA 26 0.0065
405 IRON DEFICIENCY ANAEMIA 60 0.0065
406 COMPLICATION ASSOCIATED WITH DEVICE 94 0.0065
407 ILL-DEFINED DISORDER 393 0.0065
408 SECRETION DISCHARGE 81 0.0065
409 PULSELESS ELECTRICAL ACTIVITY 27 0.0065
410 BRONCHITIS 478 0.0065
411 NERVOUSNESS 337 0.0064
412 ENDOCARDITIS 33 0.0064
413 UPPER LIMB FRACTURE 127 0.0064
414 HYPERLIPIDAEMIA 76 0.0064
415 LARGE INTESTINE POLYP 44 0.0063
416 HICCUPS 52 0.0063
417 INCREASED APPETITE 121 0.0063
418 SARCOIDOSIS 30 0.0063
419 LUNG DISORDER 307 0.0063
420 GENERAL PHYSICAL HEALTH DETERIORATION 722 0.0062
421 INSOMNIA 1661 0.0062
422 BLOOD TRIGLYCERIDES INCREASED 110 0.0062
423 BLOOD URINE PRESENT 118 0.0062
424 SOMNOLENCE 1245 0.0062
425 ROAD TRAFFIC ACCIDENT 256 0.0061
426 THROMBOSIS 490 0.0061
427 ANKLE FRACTURE 94 0.0061
428 BLOOD CHOLESTEROL INCREASED 283 0.0061
429 DYSURIA 223 0.0061
430 DECREASED APPETITE 1404 0.0060
431 CARDIAC PACEMAKER INSERTION 36 0.0060
432 HYPERVENTILATION 35 0.0060
433 BACK PAIN 1392 0.0060
434 INFLUENZA 664 0.0059
435 CONFUSIONAL STATE 962 0.0059
436 LOW DENSITY LIPOPROTEIN INCREASED 46 0.0059
437 FRACTURE 112 0.0059
438 SHOCK HAEMORRHAGIC 48 0.0059
439 WOUND 164 0.0059
440 PHOTOPSIA 37 0.0058
441 ELECTROLYTE IMBALANCE 68 0.0058
442 TYPE 2 DIABETES MELLITUS 197 0.0058
443 EATING DISORDER 124 0.0058
444 PROTEIN URINE PRESENT 29 0.0058
445 VIRAL INFECTION 193 0.0058
446 HERNIA 112 0.0058
447 LOCALISED INFECTION 140 0.0058
448 HAND FRACTURE 41 0.0058
449 MICTURITION URGENCY 66 0.0058
450 CHRONIC KIDNEY DISEASE 438 0.0058
451 CIRCULATORY COLLAPSE 98 0.0057
452 VERTIGO 348 0.0057
453 DYSPHEMIA 25 0.0057
454 ASCITES 167 0.0057
455 PIGMENTATION DISORDER 35 0.0057
456 TACHYPNOEA 77 0.0057
457 PERIORBITAL SWELLING 32 0.0057
458 CONTUSION 543 0.0056
459 FEEDING DISORDER 114 0.0056
460 URINARY RETENTION 187 0.0056
461 FOOT FRACTURE 106 0.0056
462 FEELING OF DESPAIR 26 0.0056
463 SUPRAVENTRICULAR TACHYCARDIA 53 0.0055
464 HEMIPLEGIA 46 0.0055
465 HUNGER 77 0.0055
466 ABDOMINAL DISTENSION 576 0.0055
467 SWELLING FACE 355 0.0054
468 COLON CANCER 81 0.0054
469 APATHY 79 0.0054
470 RENAL CYST 43 0.0054
471 CATARACT 322 0.0054
472 MELAENA 119 0.0054
473 ERYSIPELAS 27 0.0054
474 HYPOKALAEMIA 248 0.0054
475 MENISCUS INJURY 33 0.0054
476 EMPHYSEMA 54 0.0053
477 FOOD CRAVING 28 0.0053
478 CARDIOVASCULAR DISORDER 135 0.0053
479 HAEMATOCRIT DECREASED 105 0.0053
480 VITREOUS FLOATERS 52 0.0053
481 THROAT IRRITATION 237 0.0053
482 DEAFNESS UNILATERAL 29 0.0053
483 MUSCULOSKELETAL CHEST PAIN 81 0.0052
484 SKIN ULCER 134 0.0052
485 PRURITUS GENERALISED 112 0.0052
486 SINUS BRADYCARDIA 50 0.0052
487 PULMONARY MASS 77 0.0052
488 ABDOMINAL DISCOMFORT 867 0.0052
489 CONCUSSION 40 0.0052
490 RESPIRATORY TRACT CONGESTION 82 0.0052
491 BLOOD GLUCOSE INCREASED 970 0.0051
492 MYOCARDITIS 59 0.0051
493 DUODENAL ULCER 36 0.0051
494 POST-TRAUMATIC STRESS DISORDER 34 0.0051
495 SKIN LACERATION 55 0.0051
496 NEPHROPATHY 47 0.0050
497 LARYNGEAL OEDEMA 31 0.0050
498 OXYGEN SATURATION DECREASED 280 0.0050
499 BRAIN FOG 78 0.0050
500 MUSCLE ATROPHY 63 0.0050
501 PNEUMONIA 1608 0.0050
502 PAIN IN EXTREMITY 1460 0.0050
503 GASTROENTERITIS 72 0.0049
504 HYPONATRAEMIA 277 0.0049
505 MULTIPLE ORGAN DYSFUNCTION SYNDROME 139 0.0049
506 MUSCULAR WEAKNESS 556 0.0049
507 PELVIC FRACTURE 38 0.0049
508 PSYCHIATRIC SYMPTOM 36 0.0049
509 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 43 0.0049
510 PROTHROMBIN TIME PROLONGED 29 0.0048
511 KIDNEY INFECTION 95 0.0048
512 MOBILITY DECREASED 346 0.0048
513 STRESS CARDIOMYOPATHY 28 0.0048
514 TACHYCARDIA 423 0.0048
515 ROTATOR CUFF SYNDROME 61 0.0047
516 BLOOD LACTIC ACID INCREASED 25 0.0047
517 POLYP 31 0.0047
518 EYE DISORDER 155 0.0047
519 EOSINOPHILIA 82 0.0047
520 SINUS CONGESTION 62 0.0046
521 ACUTE CORONARY SYNDROME 38 0.0046
522 EAR DISCOMFORT 47 0.0046
523 PARAESTHESIA ORAL 66 0.0046
524 PANIC REACTION 33 0.0046
525 GENERAL PHYSICAL CONDITION ABNORMAL 31 0.0046
526 GLAUCOMA 88 0.0046
527 BLOOD THYROID STIMULATING HORMONE INCREASED 42 0.0046
528 NECK PAIN 255 0.0046
529 JOINT DISLOCATION 48 0.0045
530 HYPOTHYROIDISM 144 0.0045
531 WRIST FRACTURE 54 0.0045
532 EPISTAXIS 336 0.0045
533 OBESITY 71 0.0045
534 INCORRECT DOSE ADMINISTERED 1017 0.0045
535 HYPERCHOLESTEROLAEMIA 43 0.0044
536 AGEUSIA 111 0.0044
537 BLOOD CALCIUM INCREASED 39 0.0044
538 DYSPHAGIA 422 0.0044
539 RIGHT VENTRICULAR FAILURE 31 0.0044
540 URINE ODOUR ABNORMAL 26 0.0044
541 GASTRITIS 116 0.0044
542 BREAST PAIN 47 0.0044
543 HIATUS HERNIA 57 0.0044
544 RESPIRATORY DISORDER 130 0.0043
545 ANAL INCONTINENCE 39 0.0043
546 UROSEPSIS 40 0.0043
547 PRURITUS 1662 0.0043
548 FEELING DRUNK 32 0.0043
549 DECUBITUS ULCER 35 0.0043
550 DIABETES MELLITUS INADEQUATE CONTROL 76 0.0043
551 OROPHARYNGEAL PAIN 397 0.0043
552 BRAIN NEOPLASM 39 0.0042
553 SPINAL FRACTURE 85 0.0042
554 FLATULENCE 240 0.0042
555 OBSTRUCTIVE AIRWAYS DISORDER 47 0.0042
556 FACIAL PARALYSIS 36 0.0042
557 POST PROCEDURAL COMPLICATION 81 0.0042
558 INTERNATIONAL NORMALISED RATIO INCREASED 120 0.0042
559 HYPOXIA 148 0.0042
560 CYANOSIS 66 0.0042
561 OCULAR DISCOMFORT 47 0.0042
562 RESPIRATORY TRACT INFECTION 109 0.0042
563 HYPERHIDROSIS 537 0.0042
564 CHROMATURIA 94 0.0042
565 FLANK PAIN 39 0.0042
566 HEPATIC CYTOLYSIS 53 0.0042
567 VISION BLURRED 569 0.0041
568 COLD SWEAT 73 0.0041
569 ULCER HAEMORRHAGE 28 0.0041
570 SINUSITIS 424 0.0041
571 WHEEZING 245 0.0041
572 HYPOTONIA 41 0.0041
573 VITAMIN D DECREASED 35 0.0041
574 CARDIO-RESPIRATORY ARREST 171 0.0041
575 HYPOAESTHESIA 609 0.0041
576 TRANSIENT ISCHAEMIC ATTACK 137 0.0041
577 ARTHROPOD BITE 30 0.0040
578 BLINDNESS UNILATERAL 57 0.0040
579 BLOOD ALBUMIN DECREASED 32 0.0040
580 NEPHROLITHIASIS 185 0.0040
581 FACE OEDEMA 68 0.0040
582 FEELING COLD 112 0.0040
583 BLOOD CALCIUM DECREASED 45 0.0040
584 WRONG PRODUCT ADMINISTERED 27 0.0040
585 HYPOAESTHESIA ORAL 60 0.0040
586 ERECTILE DYSFUNCTION 102 0.0040
587 PULMONARY FIBROSIS 76 0.0040
588 DIARRHOEA 2554 0.0040
589 RHABDOMYOLYSIS 165 0.0040
590 PANIC ATTACK 144 0.0039
591 DISCOMFORT 241 0.0039
592 PULMONARY THROMBOSIS 43 0.0039
593 ARTHROPATHY 219 0.0039
594 PRODUCT USE ISSUE 735 0.0039
595 URINARY TRACT INFECTION 667 0.0039
596 NIGHTMARE 135 0.0039
597 SPUTUM DISCOLOURED 37 0.0039
598 DIVERTICULITIS 108 0.0039
599 RED BLOOD CELL COUNT DECREASED 111 0.0039
600 ARTHRALGIA 1613 0.0039
601 HAEMOGLOBIN DECREASED 398 0.0039
602 C-REACTIVE PROTEIN INCREASED 141 0.0039
603 HAEMOPTYSIS 108 0.0039
604 NERVE INJURY 43 0.0039
605 SENSORY LOSS 31 0.0038
606 POSTOPERATIVE WOUND INFECTION 26 0.0038
607 SEPSIS 429 0.0038
608 SUBDURAL HAEMATOMA 55 0.0038
609 DEPRESSION 869 0.0038
610 PRODUCT PHYSICAL ISSUE 77 0.0038
611 THINKING ABNORMAL 71 0.0038
612 PSYCHOMOTOR HYPERACTIVITY 63 0.0038
613 LACRIMATION INCREASED 114 0.0038
614 PRODUCT DISTRIBUTION ISSUE 35 0.0038
615 ACUTE RESPIRATORY FAILURE 72 0.0037
616 EOSINOPHIL COUNT INCREASED 31 0.0037
617 HYPOPHAGIA 95 0.0037
618 DISORIENTATION 147 0.0037
619 PHARYNGEAL OEDEMA 57 0.0037
620 DRY MOUTH 300 0.0037
621 ANXIETY 1051 0.0037
622 HAEMORRHOIDS 72 0.0037
623 PHOTOPHOBIA 69 0.0037
624 DECREASED IMMUNE RESPONSIVENESS 36 0.0037
625 ABNORMAL LOSS OF WEIGHT 25 0.0037
626 METABOLIC ACIDOSIS 117 0.0037
627 GAMMA-GLUTAMYLTRANSFERASE INCREASED 81 0.0037
628 QUALITY OF LIFE DECREASED 49 0.0036
629 TOOTHACHE 66 0.0036
630 MOTOR DYSFUNCTION 37 0.0036
631 EXOSTOSIS 33 0.0036
632 RESPIRATORY RATE INCREASED 32 0.0036
633 RETINAL DETACHMENT 33 0.0036
634 DYSPEPSIA 353 0.0036
635 SKIN HAEMORRHAGE 53 0.0036
636 CEREBRAL HAEMORRHAGE 128 0.0036
637 FAECES SOFT 26 0.0036
638 BLOOD TEST ABNORMAL 50 0.0036
639 HAEMORRHAGE 372 0.0036
640 PROSTATIC SPECIFIC ANTIGEN INCREASED 49 0.0036
641 ALTERED STATE OF CONSCIOUSNESS 77 0.0036
642 HAEMATOMA 92 0.0035
643 DYSARTHRIA 133 0.0035
644 PNEUMOTHORAX 56 0.0035
645 ATELECTASIS 34 0.0035
646 LIVER DISORDER 156 0.0035
647 ANAEMIA 668 0.0035
648 INCONTINENCE 37 0.0035
649 CARPAL TUNNEL SYNDROME 49 0.0035
650 SUNBURN 26 0.0035
651 SKIN DISCOLOURATION 160 0.0035
652 LUNG NEOPLASM MALIGNANT 143 0.0035
653 DEVICE MALFUNCTION 244 0.0035
654 PYELONEPHRITIS 30 0.0035
655 PROCEDURAL PAIN 96 0.0035
656 LACTIC ACIDOSIS 112 0.0035
657 MUSCLE DISORDER 28 0.0035
658 COGNITIVE DISORDER 161 0.0034
659 HAEMATURIA 118 0.0034
660 POST PROCEDURAL INFECTION 28 0.0034
661 INTENTIONAL DOSE OMISSION 98 0.0034
662 SUBARACHNOID HAEMORRHAGE 35 0.0034
663 PRODUCT USE COMPLAINT 54 0.0034
664 BLADDER DISORDER 34 0.0034
665 URINARY INCONTINENCE 101 0.0034
666 MUSCLE SPASMS 625 0.0034
667 MUSCLE TIGHTNESS 55 0.0034
668 LYMPHOCYTE COUNT DECREASED 60 0.0034
669 HYPOGLYCAEMIA 164 0.0034
670 DRUG INTERACTION 535 0.0034
671 PRODUCT ADMINISTRATION ERROR 68 0.0034
672 CHOLECYSTITIS 40 0.0034
673 ULCER 53 0.0033
674 RETCHING 71 0.0033
675 CHOLELITHIASIS 109 0.0033
676 PNEUMONIA ASPIRATION 83 0.0033
677 GASTRIC HAEMORRHAGE 38 0.0033
678 EYE HAEMORRHAGE 44 0.0033
679 GASTROINTESTINAL PAIN 36 0.0033
680 BACTERIAL INFECTION 61 0.0033
681 PNEUMONIA BACTERIAL 30 0.0033
682 MENTAL DISORDER 142 0.0033
683 PRODUCT PRESCRIBING ISSUE 71 0.0033
684 EMBOLISM 27 0.0032
685 HEPATIC FAILURE 98 0.0032
686 HEMIPARESIS 55 0.0032
687 SPINAL PAIN 38 0.0032
688 SEPTIC SHOCK 141 0.0032
689 FEMUR FRACTURE 100 0.0032
690 PARALYSIS 46 0.0032
691 UPPER GASTROINTESTINAL HAEMORRHAGE 54 0.0032
692 PALLOR 87 0.0032
693 INFLAMMATION 165 0.0032
694 GALLBLADDER DISORDER 57 0.0032
695 DEVICE RELATED INFECTION 49 0.0032
696 POST PROCEDURAL HAEMORRHAGE 37 0.0032
697 DRUG EFFECT LESS THAN EXPECTED 47 0.0032
698 MIDDLE INSOMNIA 59 0.0032
699 SKIN CANCER 68 0.0032
700 CELLULITIS 159 0.0032
701 HEPATOMEGALY 31 0.0032
702 SPINAL COMPRESSION FRACTURE 26 0.0031
703 FULL BLOOD COUNT DECREASED 63 0.0031
704 GASTROOESOPHAGEAL REFLUX DISEASE 251 0.0031
705 RESPIRATORY FAILURE 227 0.0031
706 ABDOMINAL PAIN UPPER 640 0.0031
707 HOT FLUSH 234 0.0031
708 APPENDICITIS 29 0.0031
709 MYALGIA 526 0.0031
710 ISCHAEMIC STROKE 55 0.0031
711 SPINAL OSTEOARTHRITIS 27 0.0031
712 TINNITUS 141 0.0031
713 GASTROINTESTINAL DISORDER 273 0.0030
714 CYSTITIS 97 0.0030
715 NEURALGIA 74 0.0030
716 HEPATIC CIRRHOSIS 57 0.0030
717 TREMOR 502 0.0030
718 GASTROINTESTINAL INFECTION 27 0.0030
719 DISTURBANCE IN ATTENTION 162 0.0030
720 EYE SWELLING 111 0.0030
721 SCAR 51 0.0030
722 EYE PRURITUS 100 0.0030
723 VITAMIN D DEFICIENCY 29 0.0030
724 ANOSMIA 43 0.0030
725 NEOPLASM 34 0.0030
726 PHARYNGITIS STREPTOCOCCAL 32 0.0030
727 FAECES DISCOLOURED 64 0.0029
728 ERUCTATION 57 0.0029
729 WHITE BLOOD CELL COUNT INCREASED 113 0.0029
730 HYPOMAGNESAEMIA 41 0.0029
731 RASH 1274 0.0029
732 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 50 0.0029
733 LYMPHOMA 45 0.0029
734 HERPES ZOSTER 167 0.0029
735 TOOTH FRACTURE 32 0.0029
736 PROTEINURIA 55 0.0029
737 LIVER FUNCTION TEST INCREASED 62 0.0029
738 THROAT TIGHTNESS 78 0.0029
739 HAEMATOCHEZIA 159 0.0029
740 PAIN 1760 0.0029
741 PRODUCT DOSE OMISSION 187 0.0029
742 LIP DRY 26 0.0029
743 PHOTOSENSITIVITY REACTION 47 0.0028
744 HEADACHE 1784 0.0028
745 HALLUCINATION, VISUAL 60 0.0028
746 COAGULOPATHY 47 0.0028
747 NEUROPATHY PERIPHERAL 268 0.0028
748 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
749 BLISTER 157 0.0028
750 DELIRIUM 97 0.0028
751 IMPAIRED GASTRIC EMPTYING 38 0.0028
752 INTERSTITIAL LUNG DISEASE 134 0.0028
753 INTERVERTEBRAL DISC PROTRUSION 60 0.0027
754 FREQUENT BOWEL MOVEMENTS 74 0.0027
755 JAUNDICE 73 0.0027
756 MUSCULOSKELETAL PAIN 142 0.0027
757 CHOLESTASIS 52 0.0027
758 RECTAL HAEMORRHAGE 116 0.0027
759 HEPATIC STEATOSIS 50 0.0027
760 UPPER RESPIRATORY TRACT INFECTION 124 0.0027
761 GASTROINTESTINAL HAEMORRHAGE 224 0.0027
762 MOOD ALTERED 73 0.0027
763 LOWER RESPIRATORY TRACT INFECTION 121 0.0027
764 REBOUND EFFECT 30 0.0027
765 HEPATIC FUNCTION ABNORMAL 99 0.0026
766 RENAL TUBULAR NECROSIS 26 0.0026
767 RESPIRATORY DISTRESS 73 0.0026
768 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
769 INFECTION 380 0.0026
770 PLATELET COUNT DECREASED 279 0.0026
771 TOXIC SKIN ERUPTION 26 0.0026
772 DIPLOPIA 67 0.0026
773 HEPATITIS 66 0.0026
774 TOOTH INFECTION 34 0.0026
775 AGITATION 188 0.0026
776 WOUND INFECTION 28 0.0026
777 NAUSEA 2021 0.0026
778 MALIGNANT MELANOMA 34 0.0025
779 DENTAL CARIES 28 0.0025
780 COMA 120 0.0025
781 VOMITING 1183 0.0025
782 RESPIRATORY ARREST 69 0.0025
783 TENDERNESS 26 0.0025
784 NEPHROPATHY TOXIC 28 0.0025
785 PARANOIA 43 0.0025
786 DRUG ERUPTION 44 0.0025
787 EAR INFECTION 66 0.0025
788 GASTRIC DISORDER 85 0.0025
789 CONSTIPATION 536 0.0025
790 PLATELET COUNT INCREASED 32 0.0025
791 OSTEOARTHRITIS 104 0.0025
792 FEELING HOT 148 0.0024
793 LABORATORY TEST ABNORMAL 71 0.0024
794 RESTLESSNESS 88 0.0024
795 FUNGAL INFECTION 80 0.0024
796 RASH PRURITIC 130 0.0024
797 ASTHMA 271 0.0024
798 STAPHYLOCOCCAL INFECTION 79 0.0024
799 EYE INFECTION 27 0.0024
800 HALLUCINATION 180 0.0024
801 DERMATITIS ALLERGIC 30 0.0024
802 RASH MACULO-PAPULAR 53 0.0024
803 CONDITION AGGRAVATED 724 0.0024
804 OSTEOMYELITIS 43 0.0024
805 DERMATITIS CONTACT 27 0.0024
806 ORAL PAIN 53 0.0024
807 MASS 33 0.0024
808 IMPAIRED HEALING 77 0.0023
809 GASTRIC ULCER 44 0.0023
810 CRYING 84 0.0023
811 MENTAL IMPAIRMENT 56 0.0023
812 HYPERGLYCAEMIA 83 0.0023
813 EAR PAIN 44 0.0023
814 POLYNEUROPATHY 27 0.0023
815 RESTLESS LEGS SYNDROME 41 0.0023
816 METASTASES TO LUNG 26 0.0022
817 END STAGE RENAL DISEASE 41 0.0022
818 CHILLS 261 0.0022
819 PARAESTHESIA 350 0.0022
820 MUSCULOSKELETAL STIFFNESS 194 0.0022
821 JOINT STIFFNESS 58 0.0022
822 BACTERAEMIA 26 0.0022
823 SKIN LESION 60 0.0022
824 BURNING SENSATION 153 0.0022
825 FIBROMYALGIA 53 0.0022
826 URTICARIA 364 0.0022
827 ELECTROCARDIOGRAM QT PROLONGED 78 0.0022
828 TOOTH DISORDER 48 0.0022
829 FEELING JITTERY 41 0.0021
830 ADVERSE DRUG REACTION 193 0.0021
831 BURSITIS 26 0.0021
832 ALOPECIA 420 0.0021
833 ABDOMINAL PAIN LOWER 54 0.0021
834 GINGIVAL BLEEDING 29 0.0021
835 TOOTH LOSS 44 0.0021
836 LIVER INJURY 52 0.0021
837 BASAL CELL CARCINOMA 33 0.0021
838 ADVERSE REACTION 28 0.0021
839 TENDON RUPTURE 26 0.0021
840 EXPIRED PRODUCT ADMINISTERED 69 0.0021
841 EXTRA DOSE ADMINISTERED 84 0.0021
842 MULTIPLE FRACTURES 34 0.0021
843 TENDONITIS 32 0.0021
844 IMMUNE SYSTEM DISORDER 27 0.0020
845 AGRANULOCYTOSIS 38 0.0020
846 PANCREATITIS 108 0.0020
847 SKIN DISORDER 68 0.0020
848 DRUG INEFFECTIVE 2674 0.0020
849 DEPRESSED LEVEL OF CONSCIOUSNESS 80 0.0020
850 EMOTIONAL DISORDER 62 0.0020
851 NIGHT SWEATS 64 0.0020
852 ANGER 67 0.0020
853 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 139 0.0020
854 ABSCESS 31 0.0019
855 DELUSION 30 0.0019
856 LUNG INFECTION 30 0.0019
857 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
858 OFF LABEL USE 1681 0.0019
859 RENAL INJURY 57 0.0019
860 RASH MACULAR 67 0.0019
861 HYPOCALCAEMIA 36 0.0019
862 HAEMATEMESIS 48 0.0019
863 RASH GENERALISED 49 0.0019
864 COLITIS 71 0.0019
865 PULMONARY ARTERIAL HYPERTENSION 27 0.0019
866 ABDOMINAL PAIN 433 0.0019
867 BLOOD CREATINE PHOSPHOKINASE INCREASED 53 0.0018
868 DYSGEUSIA 136 0.0018
869 THERAPY NON-RESPONDER 82 0.0018
870 LIVER FUNCTION TEST ABNORMAL 53 0.0018
871 BLOOD BILIRUBIN INCREASED 49 0.0018
872 BODY TEMPERATURE INCREASED 37 0.0018
873 PULMONARY EMBOLISM 172 0.0018
874 ASPARTATE AMINOTRANSFERASE INCREASED 96 0.0018
875 PYREXIA 623 0.0018
876 THROMBOCYTOPENIA 199 0.0018
877 CANDIDA INFECTION 30 0.0018
878 DEVICE OCCLUSION 25 0.0018
879 EYE PAIN 100 0.0018
880 BLOOD ALKALINE PHOSPHATASE INCREASED 44 0.0018
881 INTENTIONAL PRODUCT USE ISSUE 155 0.0018
882 INSURANCE ISSUE 27 0.0018
883 DRUG LEVEL INCREASED 29 0.0018
884 BRONCHOSPASM 25 0.0018
885 SEIZURE 202 0.0017
886 BONE PAIN 102 0.0017
887 HEPATIC ENZYME INCREASED 115 0.0017
888 DRY SKIN 225 0.0017
889 IRRITABLE BOWEL SYNDROME 36 0.0017
890 PROSTATE CANCER 135 0.0017
891 IRRITABILITY 100 0.0017
892 PNEUMONITIS 45 0.0017
893 THERAPY INTERRUPTED 118 0.0016
894 INJURY 116 0.0016
895 METASTASES TO LIVER 29 0.0016
896 PLASMA CELL MYELOMA 64 0.0016
897 ANAPHYLACTIC SHOCK 42 0.0016
898 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
899 TUBULOINTERSTITIAL NEPHRITIS 30 0.0016
900 BONE DISORDER 29 0.0016
901 PAIN IN JAW 45 0.0016
902 RHEUMATOID ARTHRITIS 180 0.0016
903 METASTASES TO BONE 26 0.0016
904 GYNAECOMASTIA 49 0.0016
905 OSTEOPOROSIS 65 0.0016
906 WHITE BLOOD CELL COUNT DECREASED 171 0.0016
907 SKIN EXFOLIATION 130 0.0015
908 SKIN FISSURES 30 0.0015
909 INTESTINAL OBSTRUCTION 57 0.0015
910 UNRESPONSIVE TO STIMULI 39 0.0015
911 DIABETIC KETOACIDOSIS 36 0.0015
912 MUSCLE TWITCHING 34 0.0015
913 MIGRAINE 139 0.0015
914 ABNORMAL DREAMS 40 0.0014
915 INFLUENZA LIKE ILLNESS 119 0.0014
916 DISEASE PROGRESSION 168 0.0014
917 ALANINE AMINOTRANSFERASE INCREASED 87 0.0014
918 ERYTHEMA 290 0.0014
919 DRUG-INDUCED LIVER INJURY 44 0.0014
920 TRANSAMINASES INCREASED 31 0.0014
921 DRY EYE 69 0.0014
922 NERVOUS SYSTEM DISORDER 43 0.0014
923 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0014
924 VISUAL ACUITY REDUCED 45 0.0014
925 DYSKINESIA 55 0.0014
926 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 64 0.0013
927 MENTAL STATUS CHANGES 37 0.0013
928 LYMPHADENOPATHY 47 0.0013
929 INTENTIONAL PRODUCT MISUSE 116 0.0013
930 PANCYTOPENIA 74 0.0013
931 DEEP VEIN THROMBOSIS 85 0.0013
932 EYE IRRITATION 75 0.0013
933 PANCREATITIS ACUTE 29 0.0013
934 DERMATITIS 27 0.0013
935 PSORIASIS 166 0.0013
936 BREAST CANCER 118 0.0013
937 EPILEPSY 38 0.0012
938 SYSTEMIC LUPUS ERYTHEMATOSUS 44 0.0012
939 PANCREATIC CARCINOMA 35 0.0012
940 HEPATIC CANCER 29 0.0012
941 ACCIDENTAL OVERDOSE 44 0.0012
942 DISEASE RECURRENCE 56 0.0012
943 OCULAR HYPERAEMIA 55 0.0012
944 ANAPHYLACTIC REACTION 64 0.0012
945 ECZEMA 60 0.0011
946 MOOD SWINGS 36 0.0011
947 AGGRESSION 56 0.0011
948 UNEVALUABLE EVENT 83 0.0011
949 RENAL CANCER 52 0.0011
950 GASTRIC CANCER 27 0.0011
951 RASH ERYTHEMATOUS 50 0.0010
952 HOSPITALISATION 152 0.0010
953 THERAPY CESSATION 50 0.0010
954 BLADDER CANCER 57 0.0010
955 PSORIATIC ARTHROPATHY 39 0.0010
956 STOMATITIS 57 0.0009
957 TREATMENT NONCOMPLIANCE 51 0.0009
958 SUICIDAL IDEATION 85 0.0009
959 THERAPEUTIC RESPONSE SHORTENED 30 0.0009
960 MEDICATION ERROR 49 0.0009
961 FLUSHING 88 0.0009
962 NEUTROPHIL COUNT DECREASED 33 0.0008
963 ABNORMAL BEHAVIOUR 32 0.0008
964 OVERDOSE 171 0.0008
965 COLITIS ULCERATIVE 35 0.0008
966 MULTIPLE SCLEROSIS 36 0.0008
967 SURGERY 44 0.0007
968 EMOTIONAL DISTRESS 90 0.0007
969 SKIN IRRITATION 34 0.0007
970 THERAPEUTIC PRODUCT EFFECT DECREASED 33 0.0007
971 ADVERSE EVENT 67 0.0007
972 MATERNAL EXPOSURE DURING PREGNANCY 62 0.0007
973 PRODUCT SUBSTITUTION ISSUE 39 0.0007
974 THERAPEUTIC RESPONSE DECREASED 40 0.0007
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
976 NEUTROPENIA 89 0.0007
977 ACNE 48 0.0006
978 WITHDRAWAL SYNDROME 26 0.0006
979 PRODUCT STORAGE ERROR 54 0.0006
980 MALIGNANT NEOPLASM PROGRESSION 63 0.0006
981 LEUKOPENIA 28 0.0006
982 DEVICE ISSUE 42 0.0005
983 TOXICITY TO VARIOUS AGENTS 78 0.0005
984 INJECTION SITE BRUISING 34 0.0004
985 SKIN BURNING SENSATION 28 0.0004
986 PRODUCT QUALITY ISSUE 52 0.0004
987 ACCIDENTAL EXPOSURE TO PRODUCT 35 0.0003
988 DRUG DOSE OMISSION BY DEVICE 26 0.0003
989 TREATMENT FAILURE 26 0.0003
990 DRUG ABUSE 26 0.0003
991 INJECTION SITE PAIN 81 0.0003
992 DRUG DEPENDENCE 25 0.0002